An announcement launched by the corporate knowledgeable that the grant of the patent is a testomony to Medikabazaar’s success in figuring out rising know-how alternatives and its power in progressive analysis and know-how to leverage these alternatives to profit healthcare organisations,
The corporate has additionally filed a world patent utility below the Patent Cooperation Treaty (PCT), which might give patent safety to VIZI in lots of nations. With this, Medikabazaar would be capable to train its patent in additional than 61 nations and market the product to clients throughout these nations, added the assertion.
Talking on this regard, Vivek Tiwari, CEO, Medikabazaar, mentioned, “We’re glad that VIZI’s cutting-edge know-how that makes use of AI/ML to empower key decision-makers at hospitals to make sensible selections has been granted a patent in India. To open up new home windows of alternative, we have now additionally utilized for a world patent and are certain that this will likely be granted in the end. It will enable us to ship our path-breaking merchandise and options to clients across the globe. The receipt of the patent encourages us to proceed to conduct analysis within the utility of AI to merchandise and new domains to develop instruments to leverage know-how to remodel the healthcare business.”
Since its launch in 2019, VIZI has remodeled stock administration by enabling hospitals to plan procurement of provides by offering an actionable buy record of merchandise with security or reserve inventory required to keep away from inventory out conditions and the extent of security inventory with color indicators. Hospitals don’t must take any further steps for knowledge entry to make use of this utility. VIZI permits hospitals to supply provides at the perfect costs from a single level of contact, Medikabazaar, relatively than sourcing from varied suppliers, a process that may be daunting and sometimes unrewarding, mentioned the assertion.